logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-19. New and all clients entering outpatient and inpatient treatment: distribution (percentage) by primary drug at treatment in 2005 for those countries supplying data [see all tables in this series...]

Part (iii) New clients entering inpatient treatment

CountryOpioidsCocaineStimulantsHypnotics/sedativesHallucinogensVolatile substancesCannabisOther substancesBase (known status)Status unknownTotal
Bulgaria95.70.52.10.50.00.01.10.01880188
Czech Republic21.80.152.60.90.43.020.50.77430743
Denmark23.012.616.15.70.00.042.50.087996
Ireland36.324.13.82.30.50.033.10.04440444
Greece(1)93.32.30.41.10.00.02.90.07930793
Cyprus82.68.70.00.00.00.08.70.023023
Hungary8.40.910.251.11.21.921.05.3168641690
Romania53.80.61.812.40.01.24.325.86513654
Slovakia17.40.632.47.20.99.930.01.53330333
Finland30.60.026.214.20.01.626.21.11830183
Sweden23.03.136.017.60.20.316.93.05750575
United Kingdom(2)73.114.73.52.00.20.45.01.096416980
Turkey38.44.77.43.20.016.528.71.293514949
Total40.54.814.215.50.43.417.24.07605467651

Notes:

 Only countries supplying data are reported. 

 (1) In case of Greece 'Speedball' is included under the category 'other substance'. 

 (2) Data refer to collection period between 01.04.2004 and 31.03.2005. 

 See also 'General notes for interpreting data' on the Explanatory notes and help page

Sources:

 2006 Reitox national reports - TDI - inpatient treatment centres.  

Page last updated: Monday, 12 November 2007